CorMedix Inc. Business Operations Contracts & Agreements
9 Contracts & Agreements
- Development Agreements (2 contracts)
- Indemnification Agreements (2)
- Sales Agreements (3)
- Services Agreements (1)
- Supply Agreements (1)
- Form of Indemnification Agreement between the Company and each of its directors and executive officers (Filed With SEC on May 15, 2023)
- Sales Agreement dated August 12, 2021 (Filed With SEC on August 12, 2021)
- Sales Agreement dated November 27, 2020 (Filed With SEC on November 27, 2020)
- Amendment No. 1, dated December 8, 2017, to At-the-Market Issuance Sales Agreement, dated April 8, 2015, between CorMedix Inc. and B. Riley FBR, Inc (Filed With SEC on December 8, 2017)
- Form of Indemnification Agreement (Filed With SEC on June 27, 2017)
- Preliminary Services Agreement dated April 8, 2015, between CorMedix Inc. and [RC]2 Pharma Connect LLC (Filed With SEC on August 6, 2015)
- Taurolidine Supply Agreement, dated December 7, 2009 by and between CorMedix Inc. and Navinta, LLC (Filed With SEC on February 6, 2015)
- GLOBAL DEVELOPMENT PLAN DEFERIPRONE JUNE 2011 CorMedix Inc. 745 Rt. 202-206, Suite 303, Bridgewater, New Jersey 08807 V2.8 (13 June 2011) (Filed With SEC on November 10, 2011)
- Exhibit 5.1 A Clinical Development Timeline for Shiva 102 (Filed With SEC on November 10, 2011)
